Navigation Links
REOLYSIN in Medical News

Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells

...id neurosurgeon John S. Yu, M.D., director of Surgical Neuro-oncology at Cedars-Sinais Department of Neurosurgery. Yu is principal investigator of the reolysin clinical trial at Cedars-Sinai. According to the protocol of this open-label Phase I and II trial, patients will receive a single treatment of REO...

Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials

...terim results from a U.K. Phase Ia/Ib combination reolysin and radiation clinical trial for patients with adv...the trial received two intratumoural treatments of reolysin at dosages of 1x108, 1x109, or 1x1010 TCID50 with ...ved either two, four or six intratumoural doses of reolysin at 1x1010 TCID50 with a constant localized radiati...

Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs

... investigators examining various co-therapies with reolysin is providing Oncolytics with the rationale for its...fficer at Oncolytics. "This research suggests that reolysin can be combined with many existing therapies that ...he treatment of cancer patients." Currently, reolysin is being used in Phase I and Phase I/II human clin...
REOLYSIN in Medical Technology

Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial

CALGARY, June 05, 2007 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") announced today positive results from its U.S. Phase I clinical trial examining the systemic administration of REOLYSIN(R) in patients with advanced cancers. The results indicate that REOLYSIN(R) can be delivere...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...
REOLYSIN in Biological News

Oncolytics Biotech, Inc. announces publication of research

...appears online in the January 1, 2008 issue of Clinical Cancer Research. This exciting Mayo Clinic work supported the initiation of our combination reolysin and cyclophosphamide clinical trial, recently approved by the U.K. health authorities, said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. ...

Dealing deadly cancers a knockout punch

...melanomas. Recent studies also indicate that reolysin works synergistically with standard anti-cancer dr...ther studies completed in the past year have shown reolysin has the ability to prime patients' immune systems ...ond "inflammatory" mechanism that researchers hope reolysin will bring about long-term remissions of once-untr...
REOLYSIN in Biological Technology

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...ed by our investigators, reinforce our belief that reolysin has the potential to significantly improve treatme...ASCO demonstrating that the combination of reolysin and gemcitabine in a U.K. Phase I trial was well t... - Presented a poster at ASCO that indicated reolysin was well tolerated and demonstrated anti-t...

Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)

...y completed an initial 100-litre production run of reolysin under cGMP conditions. This run is anticipated to ...s, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely comp...

Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)

...the lyophilization process, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...

Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

...ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...

Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial

...e Phase II component of a Phase I/II U.K. trial of reolysin combined with paclitaxel/carboplatin for patients ... Phase III pivotal program now being developed for reolysin in combination with carboplatin/paclitaxel for hea...atory Phase II trial using the same combination of reolysin and carboplatin/paclitaxel for patients with head ...

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting

...ntation, entitled "A Phase II Study of Intravenous reolysin (Wild-type Reovirus) in the Treatment of Patients ...es in whom the IDD group are investigating various reolysin regimens," said Dr. Frank Giles, Director, IDD, an... Deputy Director, CTRC at UTHSCSA. Additional reolysin results presented Two additional poster prese...

Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference

...d today that data from three clinical trials using reolysin are scheduled to be presented at the 2009 American...he ASCO website today at www.asco.org . reolysin poster presentations - Dr. Monica Mita and ... I Study of the Combination of Intravenous reolysin (REO) and Gemcitabine (GEM) in Patients (pts) ...

Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study

... antitumour activity of intravenous, multiple dose reolysin in patients with bone and soft tissue sarcomas metastatic to the lung. reolysin is delivered intravenously to patients at a dose o...al and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...

Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results

...l benefit in the majority of patients treated with reolysin in combination with chemotherapy or radiation, pav... results from a U.K. Phase I/II combination reolysin and paclitaxel/carboplatin trial for patients with...Announced positive results from a U.K. combination reolysin and docetaxel trial for patients with a var...

Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting

... results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of phar...
Other Tags
(Date:7/9/2014)... Montefiore Medical Center and the Albert ... present new findings at the Alzheimer,s Association International Conference ... Copenhagen, Denmark. Data from the four abstracts will focus ... to mild cognitive impairment and dementia. The research is ... in 1980 to examine healthy brain aging as well ...
(Date:7/9/2014)... organs in the human body. Its job is to ... is its synthesis function and that toxic substances ... detoxification function. Lack of exercise and too much alcohol, ... resulting diseased cells can lead to inflammations, cancerous ulcers, ... the German Liver Foundation, over five million people in ...
(Date:7/9/2014)... published in the scientific journal Nature Neuroscience ... at Universit Laval, reveals that it is possible to ... rekindling pain so that it can subsequently be erased. ... chronic pain. , The researchers from the Faculty of ... mentale de Qubec (IUSMQ) were inspired by previous work ...
(Date:7/8/2014)... Defense Advanced Research Projects Agency (DARPA) awarded Lawrence ... to develop an implantable neural device with the ... brain to help restore memory, DARPA officials announced ... understanding that memory is a process in which ... information, store it and retrieve it. Certain types ...
(Date:7/8/2014)... obesity have increased risks of dying at a young ... disease, stroke, diabetes, and kidney and liver diseases, according ... 20 large studies of people from three countries. The ... (NCI), part of the National Institutes of Health, found ... a dramatic reduction in life expectancy compared with people ...
Breaking Medicine News(10 mins):Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Discovery of a new means to erase pain 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3Health News:NCI study finds extreme obesity may shorten life expectancy up to 14 years 2
(Date:7/9/2014)... to switch out one gene for another in a ... science fiction to reality within this decade. As with ... hope of fixing disease-causing genes in humans, for example--as ... have put one of those concerns to rest: using ... occurrence of mutations in the cells. The new results ...
(Date:7/9/2014)... LAFAYETTE, Ind. - Regulated deer hunts in Indiana state ... from decades of damage caused by overabundant populations of ... team led by Michael Jenkins, associate professor of forest ... Resources policy of organizing hunts in state parks has ... and wildflowers rendered scarce by browsing deer. , ...
(Date:7/9/2014)... from the Spanish National Cancer Research Centre (CNIO) have ... cells, also regulates cell division in stratified epitheliathose that ... cover the oesophagus or the vaginain adult organisms. According ... journal Nature Communications , this factor could also ... from stratified epithelia of the oesophagus and skin. , ...
Breaking Biology News(10 mins):No extra mutations in modified stem cells, study finds 2No extra mutations in modified stem cells, study finds 3Hunting gives deer-damaged forests in state parks a shot at recovery 2CNIO scientists discover that pluripotency factor NANOG is also active in adult organisms 2
Other Contents